Publicacións en colaboración con investigadores/as de Hospital de Sabadell (9)

2018

  1. Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476

2017

  1. Adding access blood flow surveillance reduces thrombosis and improves arteriovenous fistula patency: A randomized controlled trial

    Journal of Vascular Access, Vol. 18, Núm. 4, pp. 352-358

  2. Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity

    Medicine (United States), Vol. 96, Núm. 8

2016

  1. Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study

    Annals of Oncology, Vol. 27, Núm. 7, pp. 1273-1279

  2. The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: A randomized clinical trial

    Journal of Vascular Access, Vol. 17, Núm. 1, pp. 13-19

2015

  1. Nationwide study on the use of intravascular catheters in internal medicine departments

    Journal of Hospital Infection, Vol. 90, Núm. 2, pp. 135-141

2013

  1. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain

    Vaccine, Vol. 31, Núm. 46, pp. 5486-5494

2008

  1. Family impact of rotavirus gastroenteritis in children under two years

    Anales de Pediatria, Vol. 69, Núm. 6, pp. 515-520

2001

  1. Abscesos esplénicos y enfermedad por arañazo de gato

    Anales Espanoles de Pediatria, Vol. 55, Núm. 4, pp. 365-368